Ms. Denise Faltischek reports

TILRAY MEDICAL LAUNCHES REDECAN CANNABIS BRAND IN AUSTRALIA

Tilray Medical, a division of Tilray Brands Inc. and a global leader in medical cannabis, empowering the therapeutic alliance between patients and health care practitioners to make informed individualized health decisions, has launched Redecan EU-GMP-certified (European Union good manufacturing practice) medical cannabis products in Australia.

Denise Faltischek, chief strategy officer and head of international, Tilray Brands, said: "The launch of Redecan, a premium cannabis brand, in Australia is another significant milestone for Tilray Medical as we relentlessly pursue our vision of making high-quality medical cannabis products accessible to patients worldwide. The launch of Redecan further expands our medical cannabis portfolios alongside our current Tilray and Broken Coast offerings as we continue our mission of empowering patients and health care practitioners to find the optimal therapeutic solutions."

Jonathan Trodden, director, Tilray Medical Australia, added: "We are proud to launch Redecan in Australia and further strengthen our ongoing commitment to providing patients with a consistent, accessible supply of premium-quality medical cannabis to choose from."

The following Redecan products are now available for medical cannabis patients in Australia:

• Redecan PC THC28 Purple Churro -- 15 grams;
• Redecan SA THC28 Space Age Cake -- 15 grams.

Tilray continues to be one of the leading providers of EU-GMP-certified medical cannabis to patients, physicians, pharmacies, hospitals, governments and researchers across the globe and today offers a comprehensive portfolio of THC (tetrahydrocannabinol) and CBD (cannabidiol) products in over 20 countries. In furtherance of its mission, Tilray has supported medical trials globally studying the efficacy of medical cannabis as a treatment for indications including fibromyalgia, pediatric epilepsy, refractory pediatric epilepsy, cancer-induced nausea and vomiting, HIV, essential tremor, breast cancer disorders, posttraumatic stress disorder, and alcohol use disorders.

About Tilray Medical

Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, Symbios and Navcora. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first EU-GMP-certified cannabis production facilities in Europe, specifically in Portugal and Germany simultaneously. Today, Tilray Medical is one of the largest suppliers of medical cannabis to patients, physicians, hospitals, pharmacies, researchers and governments in 20 countries and across five continents.

About Tilray Brands Inc.

Tilray Brands is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness and entertainment, elevating lives through moments of connection. Tilray's mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray's unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and craft beverages.

We seek Safe Harbor.